Macular Degeneration Treatment Market 2023 | Share, Growth Outook, Research Report 2028
How Big is the Macular Degeneration Treatment Market ?
IMARC Group’s latest report, titled “Macular Degeneration Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, the global macular degeneration treatment market size reached US$ 8.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 12.9 Billion by 2028, exhibiting a growth rate (CAGR) of 6.2% during 2023-2028.
What is Macular Degeneration Treatment ?
Macular
degeneration treatment refers to medical interventions and therapies that focus
on managing and mitigating the effects of macular degeneration, which is a
progressive eye condition. It comprises a range of strategies, such as
medication, surgical procedures, and lifestyle modifications, to improve visual
function in individuals afflicted by this condition. It can be treated through
anti-angiogenic drugs that prevent blockages and leakages in the blood
vessels.
Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/macular-degeneration-treatment-market/requestsample
Who are the key Players Operating in the Industry ? :
- Aerie Pharmaceuticals Inc.
- Bausch Health Companies Inc.
- Bayer AG
- F. Hoffmann-La Roche Ltd
- Iveric Bio Inc.
- Novartis AG
- Panoptica
- Pfizer Inc.
- Phio Pharmaceuticals
- Regeneron Pharmaceuticals Inc.
- Regenxbio Inc.
- Santen Pharmaceutical Co. Ltd.
What are the Growth Prospects and Trends in the Macular Degeneration Treatment Industry ? :
At present,
the rising awareness about the importance of early disease detection among
individuals, along with the improved diagnostic methods that enhance treatment
effectiveness, represents one of the major factors strengthening the growth of
the market.
Besides
this, the increasing preference for gene therapy and regenerative medicine that
offer promising prospects for innovative macular degeneration is contributing
to the growth of the market. Moreover, the rising popularity of personalized
medicine to improve patient outcomes due to the increasing focus on
patient-centric approaches in healthcare facilities worldwide is bolstering the
growth of the market.
Apart from
this, the growing demand for effective treatments and therapies due to the
rising incidences of macular degeneration among individuals across the globe is
positively influencing the market. In line with this, the increasing number of
insurance coverage policies for eye care and treatments to reduce financial
barriers for patients is supporting the growth of the market.
Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/macular-degeneration-treatment-market
Key Market Segmentation:
Breakup by Type:
- Dry Age-related Macular
Degeneration
- Wet Age-related Macular
Degeneration
Breakup by Stage of Disease:
- Early Stage
- Intermediate Stage
- Late Stage
Breakup by Route of
Administration:
- Intravenous Route
- Intravitreal Route
Breakup by End User:
- Hospitals
- Ambulatory Surgical Center
- Others
Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key Highlights of the Report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800